Research focus
Recurring themes across recent publications include Enzyme Ace2, Angiotensin-Converting Enzyme. Work appears regularly in Nature, Cell, Nature Medicine. See the publication list below for the most-cited works compiled from OpenAlex.
Recent publications
- Cerebral organoids model human brain development and microcephalyDOI
- Molecular characterization of mitochondrial apoptosis-inducing factorDOI
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus鈥搃nduced lung injuryDOI
- OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesisDOI
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic targetDOI
- Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4DOI
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENDOI
- Angiotensin-converting enzyme 2 protects from severe acute lung failureDOI
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2DOI
- Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligandDOI
The lab page does not clearly state student acceptance status. Email the professor directly to confirm.
How to apply
Email Josef Penninger 6-12 months before your application deadline. Read several recent papers and reference specific work in your message. Use our how to email a Japanese professor guide for the proven email structure.
For applications via MEXT scholarship: see our MEXT 2027 complete guide and university-specific University Recommendation track.
External profiles
- ORCID: https://orcid.org/0000-0002-8194-3777
- OpenAlex: openalex.org
Profile compiled from public sources (Researchmap, OpenAlex, The University of Tokyo faculty directory). Last refreshed 2026-05. Report incorrect information.